Formula
Our unique blend of probiotics is filled with 6 billion live microorganisms of good bacteria - including one of the highest concentrations available on the market of Streptococcus salivarius (BLIS K12) & Streptococcus salivarius (BLIS M18)
What’s BLIS K12?
With over 30 years of published research backing it up, this wonder ingredient helps maintain ear, nose, and throat health. It begins in the mouth and from there it works to support overall health and wellness. This includes supporting a healthy oral cavity, establishing and maintaining a healthy balance of beneficial bacteria, and promoting upper respiratory health. To top it off, BLIS K12 has antimicrobial activity against bacteria involved in halitosis.** Time to blast away bad breath!
What’s BLIS M18?
Like its partner in crime BLIS K12, BLIS M18 hails from a common and beneficial strain of oral bacteria found naturally in the mouth and throat. On top of providing many of the same benefits as BLIS K12, this handy helper is a strong supporter of healthy teeth and gums for a beautiful smile.
6 billion CFU
CF-say what now? This not-so-common acronym stands for colony-forming unit, and it refers to the number of active and live microorganisms in each serving of your BURST Oral Probiotics at the time of manufacture. That means every lozenge contains an incredible array of BLIS K12, MI8, and other beneficial bacteria, and you can expect at least 2 billion of these wellness wonders to still be there when you take your probiotics before their expiration date.
Other Ingredients: Isomalt, Inulin, Stearic Acid, Spearmint flavor (natural), Dicalcium Phosphate, Stevia Leaf Extract (Stevia rebaudiana).
Contains: Milk (may contain trace elements of milk protein from the fermentation process.) There is no dairy added in lozenges manufacture. Made without wheat, gluten, soy, eggs, tree nuts, peanuts, fish or shellfish.
*Burton, J.P., C.N. Chilcott, C.J. Moore, G. Speiser, and J.R. Tagg. 2006. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. Journal of Applied Microbiology 100(4):754-764 https://pubmed.ncbi.nlm.nih.gov/16553730/
** Masdea, L., Kulik, E. M., Hauser-Gerspach, I., Ramseier, A. M., Filippi, A., & Waltimo, T. (2012). Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Archives of Oral Biology, 57(8), 1041-1047. doi: 10.1016/j.archoralbio.2012.02.011. Source https://pubmed.ncbi.nlm.nih.gov/22405584/